Background Image
Table of Contents Table of Contents
Previous Page  39 / 492 Next Page
Information
Show Menu
Previous Page 39 / 492 Next Page
Page Background

BSP-4

(P)

CAN RENAL FIBROSIS DUE TO PYELONEPHRITIS BE PREVENTED? : AN

EXPERIMENTAL STUDY

Mujdem Nur AZILI

1

, Esra KARAKUS

2

, Atilla SENAYLI

1

and Tugrul TIRYAKI

3

1) Ankara Child Diseases Hematology and Oncology Education and Research Hospital, Pediatric surgery, Ankara, TURKEY

- 2) Ankara Child Diseases Hematology and Oncology Education and Research Hospital, Pathology, Ankara, TURKEY - 3)

Ankara Child Diseases Hematology and Oncology Education and Research Hospital, Pediatric Surgery and Pediatric

Urology, Ankara, TURKEY

PURPOSE

The circulating renin-angiotensin system (RAS) regulates arterial pressure and sodium homeostasis. But inappropriate

activation of intrarenal RAS causes increased Angiotensin II (Ang II) levels that lead to renal injury, proliferation and

fibrosis. There are alternative pathways too; forming Ang II, probably a chymase. Chymase is secreted from mast cells.

An experimental study was performed to investigate the efficacy of captopril and ketotifen, which are ACE inhibitor and

mast cell stabilizer, on the prevention of scar formation after acute pyelonephritis.

MATERIAL AND METHODS

Acute pyelonephritis was created by injecting E. coli suspension into renal cortex. Fifty rats were divided to five equal

groups. Group A (sham) animals were given SF inoculums. Group B rats were given E. coli suspension. Group C rats

were given E. coli suspension and treated with cephotaxime. Group D rats were given E. coli and received cephotaxime

and captopril (50 mg/kg/day) via orogastric lavage. Group E rats were given E. coli and received cephotaxime and

ketotifen (1 mg/kg/day) via oral route.

RESULTS

To assess the efficacy of captopril and ketotifen for prevention of renal fibrosis, the rats were sacrified under anesthesia,

six weeks after the bacterial inoculation to determine degree of inflammation, abscess formation, scar formation. The

scores of inflamatuar criteria's increased significantly in the groups of B compared with the sham group (A) (p=0.001).

Captopril or ketotifen treatment with antibiotic were found to be the only factor decreasing scar formation (p=0.007).

The percentage of scar formation was 20% in the group of E, 50% in the group of D while 90% in the group of C. But

there was no significant difference between group D and E in the efficacy of preventing scar formation.

CONCLUSIONS

We conclude that captopril and ketotifen have a preventive effect in the development of renal fibrosis in an experimental

model of acute pyelonephritis in rats.